facility in Greenfield to keep a toxicology complex running; economic development officials in Sullivan, Tenn.
say GlaxoSmithKline is actively pursuing a buyer to maintain a penicillin and
amoxicillin plant that it will be decommissioning. While the community may
be losing a business, notes Richard
Venable, CEO, NETWORKS-Sullivan
Partnership, the new occupant of the
facility will have access to a trained
workforce.
The Sullivan County region is
home to the headquarters for King
Pharmaceuticals and Graceway
Pharmaceuticals, LLC. The county is
ideal not just for the manufacture of
pharmaceuticals but also for the distribution of the products, says Jack
Lawson, director of economic development, NETWORKS-Sullivan
Partnership. For instance, Graceway
has manufacturing facilities located
throughout North America and is
able to tap into the advantages
Sullivan County offers in regard to
logistics needs, including Foreign
Trade Zone designation status and
access to interstates 81 and 26. “We
are nine hours from 77 percent of
the U.S. population,” Venable says.
The community is also within 15
minutes of three lakes, which provide the abundant fresh water that is
required by biopharma companies.
What’s more, in addition to the
GlaxoSmithKline manufacturing
facility, Sullivan County has 600
acres available in industrial and business park acreage. “We have recently
purchased 322 acres in Bristol,
which includes rail services,” Venable
says. “And we have 166 acres of
business parks located at the intersection of interstates 81 and 26.”
Moving north to New Jersey, a nascent biopharma cluster is developing
in the city of Vineland, where the
industry can access state-issued Urban
Enterprise Zone status. The community
has also established a fund for economic development which is a revolving
loan fund that provides long-term
mortgages of up to 20 years at a rate
of 5 percent. “What is working to our
advantage, even though New Jersey is
not the lowest cost state in the country
to do business, this 20-year fixed rate
mortgage will accept a second lien position, allowing a primary lender in front
of us so we can leverage our funds even
further,” says Jim Lelli, director of economic development, city of Vineland.
Another property related incentive in
Vineland is that the city’s industrial
commission buys and builds industrial
parks. “We acquire the land, subdivide
it, run the infrastructure to the curb,
able to keep a lid on prices,” Lelli notes.
“We don’t want to compete with commercial developers, but we don’t want
the prices to get out of hand.”
Lelli says the land becomes an incentive, at $45,000 an acre with utilities in
place, which is quite lower than prices
ENSURING PROPER SET UP OF REGULATED SYSTEMS
BY RAY BOUKNIGHT
There are many challenges that pharmaceutical and
life sciences companies face when relocating or expanding their research facilities to make sure all the moving
pieces are reconnected properly and within strict industry guidelines for validation. There are many things that
need to be considered including proper power for the
equipment, physical security, HVAC considerations, air
cleanliness, separation of processing lines to avoid contamination, easily cleanable floors, walls and ceilings and
proper temperature and humidity controls to name only
a few. Here are some things to consider during the transfer and installation of regulated systems.
If the systems are already in use, there should be existing documentation that defines the current configuration
of the system. This is commonly referred to as
Installation Qualification (IQ) documentation. The IQ
establishes the documented evidence that the hardware
platform and the supporting infrastructure components
have been installed according to the manufacturer, vendor or custom-developed installation specifications. It
documents verification of how the components of the
system were installed, when they were installed, who
was responsible for the installation, the qualifications of
the installers, and documents specifics regarding the
installed components. After installation, a performance
qualification should be performed to ensure that a system performs as intended in the specified operating
range. This execution process is conducted using a
company-specific predefined dataset or actual live data.
If this documentation does not already exist, then an
as-is set of documentation should be generated to have
evidence of the current configuration for the current processing. This documentation would then be used during
the install process for the new location of the equipment.
Lastly, there should be Standard Operating Procedures
(SOP) that document the everyday processes. The SOPs
are designed to support system operating environments
and to specify procedures necessary for a system to
remain in a validated state. Controls and procedures
should (as a minimum) cover the following areas:
* Problem reporting
* Change management/configuration management
* Backup/recovery/archiving
* Operating procedures
(system use, system administration)
* Periodic reviews
* Training
* Security administration
* Database administration (where applicable)
There are other validation documents associated with
this process. Additional information can be found at
www.interphasesystems.com / services_validation.asp.
Ray Bouknight is the director of validation and
compliance at Interphase Systems, Inc. Learn more
at www.interphasesystems.com.